Security key
M96088105
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 13,444,839
- Total 13F value
- $109,243,080
- Share change
- -697,426
- SEC-reported price per share
- $8.19
- Number of holders
- 60
- Value change
- -$6,040,297
- Number of buys
- 18
- Number of sells
- 48
- Shares outstanding
- 48,684,257
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
60
Top holders
10
URGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Ownership snapshot
Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MENORA MIVTACHIM HOLDINGS...
Disclosed value leader
MENORA MIVTACHIM HOLDINGS...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 6.1%
Showing 1-6 of 15 holder rows.
Quick read
MENORA MIVTACHIM HOLDINGS LTD. leads the comparable SEC ownership view at 6.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MENORA MIVTACHIM HOLDINGS LTD.'s linked filing trail.
Comparable ownership
Top 5
MENORA MIVTACHIM HOLDINGS LTD.
6.1%
BlackRock Finance, Inc.
3.5%
CREDIT SUISSE AG/
2.2%
Harel Insurance Investments & Fin...
2.1%
GREAT POINT PARTNERS LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
6.1%
|
$25,716,000
2,952,489 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3.5%
|
$14,816,000
1,700,776 shares
|
— | 31 Mar 2022 |
| CREDIT SUISSE AG/ |
13F
Company
|
2.2%
|
$9,456,000
1,085,519 shares
|
— | 31 Mar 2022 |
| Harel Insurance Investments & Financial Services Ltd. |
13F
Company
|
2.1%
|
$8,933,000
1,025,633 shares
|
— | 31 Mar 2022 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
1.8%
|
$7,608,000
873,424 shares
|
— | 31 Mar 2022 |
| RTW INVESTMENTS, LP |
13F
Company
|
1.8%
|
$7,469,000
857,464 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
60
Shares
13,444,839
Rows available
60
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
82
Q2 2022 holders
60
Holder diff
-22
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend